Clinical trial
Identification of New Biomarkers for Patients With Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) - do They Provide New Information Regarding Diagnosis, Treatment Efficacy, Side Effects, or Prognosis?
NCT05184400 is registered in ClinicalTrials.gov with Herlev and Gentofte Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identification of New Biomarkers for Patients With Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer) - do They Provide New Information Regarding Diagnosis, Treatment Efficacy, Side Effects, or Prognosis?
- Lead sponsor
- Herlev and Gentofte Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 1, 2015
- Completion date
- December 31, 2030
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biliary tract cancer, cholangiocarcinoma, gallbladder cancer